Inhibition of PKM2 sensitizes triple-negative breast cancer cells to doxorubicin
- Type
- Retraction
- Notice date
- 10/29/2014 0:00
- Journal
- Biochemical and Biophysical Research Communications (BBRC)
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.bbrc.2014.10.109
- Original paper DOI
- 10.1016/j.bbrc.2014.10.109